SEATTLE, Oct. 29 /PRNewswire-FirstCall/ -- Dendreon Corporation (NASDAQ: DNDN) today announced that management will present at the following upcoming investor conferences. Merriman Investor Summit 2009 New York City Tuesday, November 10, 2009 11:00 a.m. ET Credit Suisse 2009 Healthcare Conference Phoenix, Arizona Friday, November 13, 2009 11:30 a.m. ET Lazard Capital Markets 6th Annual Healthcare Conference New York City Tuesday, November 17, 2009 10:55 a.m. ET The presentations will be audio webcast live and available for replay from Dendreon's website, http://www.dendreon.com/. Dendreon Corporation is a biotechnology company whose mission is to target cancer and transform lives through the discovery, development and commercialization of novel therapeutics. The Company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy product candidates designed to stimulate an immune response. Dendreon is also developing an orally-available small molecule that targets TRPM8 that could be applicable to multiple types of cancer as well as benign prostatic hyperplasia. The Company has its headquarters in Seattle, Washington and is traded on the Nasdaq Global Market under the symbol DNDN. For more information about the Company and its programs, visit http://www.dendreon.com/. DATASOURCE: Dendreon Corporation CONTACT: Jennifer Williams, Investor Relations of Dendreon Corporation, +1-206-829-1500 Web Site: http://www.dendreon.com/

Copyright